Last reviewed · How we verify
Estron (ESTRONE)
At a glance
| Generic name | ESTRONE |
|---|---|
| Sponsor | Watson Labs |
| Drug class | estrone |
| Target | Estrogen receptor |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
| First approval | 1979 |
Approved indications
- Acne vulgaris
- Chemotherapy-induced nausea and vomiting
- Contraception
- Prevention of Post-Operative Nausea and Vomiting
- Prevention of Radiation-Induced Nausea and Vomiting
Common side effects
Drug interactions
- atazanavir
- darunavir
- fosamprenavir
- fosphenytoin
- letrozole
- nelfinavir
- phenobarbital
- phenytoin
- saquinavir
- tipranavir
Key clinical trials
- An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin (PHASE1)
- A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After Menopause (PHASE1)
- A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity (PHASE1)
- A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives (PHASE1)
- A Study of Elenestinib in Healthy Adult Female Participants (PHASE1)
- Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring (PHASE3)
- A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies (PHASE1)
- Ovulation Incidence in Oral Contraceptive Users (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |